Vemurafenib companion diagnostic - Roche/Plexxikon

Drug Profile

Vemurafenib companion diagnostic - Roche/Plexxikon

Alternative Names: cobas 4800 BRAF V600 Mutation Test

Latest Information Update: 15 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Plexxikon; Roche Diagnostics
  • Developer Roche Diagnostics
  • Class Diagnostic agents
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Malignant melanoma

Most Recent Events

  • 02 Dec 2014 Registered for Diagnostic tests in Japan (unspecified route)
  • 02 Dec 2014 Registered for Malignant melanoma (Diagnosis) in Japan (unspecified route)
  • 06 Dec 2012 Roche plans a non-interventional study for Malignant melanoma diagnosis in France (NCT01744860)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top